Your browser doesn't support javascript.
loading
Population pharmacokinetics and dosing considerations of daptomycin in critically ill patients undergoing continuous renal replacement therapy.
Xie, Feifan; Li, Sanwang; Cheng, Zeneng.
Affiliation
  • Xie F; Division of Biopharmaceutics and Pharmacokinetics, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China.
  • Li S; Department of Pharmacy, Medical College, Hunan Normal University, Changsha, China.
  • Cheng Z; Division of Biopharmaceutics and Pharmacokinetics, Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China.
J Antimicrob Chemother ; 75(6): 1559-1566, 2020 06 01.
Article in En | MEDLINE | ID: mdl-32083673
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Staphylococcal Infections / Daptomycin / Continuous Renal Replacement Therapy Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: J Antimicrob Chemother Year: 2020 Document type: Article Affiliation country: China Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Staphylococcal Infections / Daptomycin / Continuous Renal Replacement Therapy Type of study: Guideline / Prognostic_studies Limits: Humans Language: En Journal: J Antimicrob Chemother Year: 2020 Document type: Article Affiliation country: China Country of publication: United kingdom